AAAAAA
Results:
1-7
|
Results: 7
Authors:
Indrova, M
Bubenik, J
Simova, J
Vonka, V
Nemeckova, S
Mendoza, L
Reinis, M
Citation: M. Indrova et al., Therapy of HPV 16-associated carcinoma with dendritic cell-based vaccines:In vitro priming of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide, INT J MOL M, 7(1), 2001, pp. 97-100
Authors:
Indrova, M
Bubenik, J
Simova, J
Bieblova, J
Jandlova, T
Smahel, M
Vonka, V
Glazman-Kusnierczyk, H
Pajtasz-Piasecka, E
Radzikowski, C
Mikyskova, R
Citation: M. Indrova et al., Chemoimmunotherapy of cancer: Potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A, ONCOL REP, 8(6), 2001, pp. 1371-1374
Authors:
Mendoza, L
Indrova, M
Hajkova, R
Reinis, M
Smahel, M
Vonka, V
Bubenik, J
Jandlova, T
Citation: L. Mendoza et al., Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth, FOL BIOL, 46(3), 2000, pp. 91-97
Authors:
Sobota, V
Indrova, M
Rossner, P
Bubenik, J
Jandlova, T
Citation: V. Sobota et al., CD80 and IL-2 signals cooperate in the regression of tumors transplanted in congenitally athymic mice, ONCOL REP, 6(3), 1999, pp. 669-673
Authors:
Hajkova, R
Indrova, M
Jandlova, T
Bubenik, J
Reinis, M
Citation: R. Hajkova et al., Interleukin 2 gene therapy of surgical minimal residual tumour disease: Characterization of cytolytic effector cells from tumour progressors and regressors, FOL BIOL, 45(6), 1999, pp. 227-231
Authors:
Rossner, P
Bubenik, J
Sobota, V
Indrova, M
Hajkova, R
Mendoza, L
Jandlova, T
Simova, J
Citation: P. Rossner et al., Granulocyte-macrophage colony-stimulating factor-producing tumour vaccines, FOL BIOL, 45(5), 1999, pp. 173-177
Authors:
Indrova, M
Pajtasz-Piasecka, E
Jandlova, T
Simova, J
Bubenik, J
Radzikowski, C
Citation: M. Indrova et al., IL-2 gene-modified tumour vaccines: Monitoring of IL-2 levels in serum andperitoneal cavity of vaccinated mice, FOL BIOL, 45(1), 1999, pp. 7-11
Risultati:
1-7
|